1 week Down -31.1% in 4 Weeks, Here’s Why You Should You Buy the Dip in Relay Therapeutics (RLAY) Zacks

The heavy selling pressure might have exhausted for Relay Therapeutics (RLAY) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Earnings · Wall Street